• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过体内氢磁共振波谱法估计不同乳腺组织和各种乳腺肿瘤亚型中的脂肪分数来研究脂质代谢。

Study of lipid metabolism by estimating the fat fraction in different breast tissues and in various breast tumor sub-types by in vivo H MR spectroscopy.

作者信息

Agarwal Khushbu, Sharma Uma, Mathur Sandeep, Seenu Vurthaluru, Parshad Rajinder, Jagannathan Naranamangalam R

机构信息

Department of NMR & MRI Facility, All India Institute of Medical Sciences, New Delhi, Delhi 110029, India.

Department of Pathology, All India Institute of Medical Sciences, New Delhi, Delhi 110029, India.

出版信息

Magn Reson Imaging. 2018 Jun;49:116-122. doi: 10.1016/j.mri.2018.02.004. Epub 2018 Feb 14.

DOI:10.1016/j.mri.2018.02.004
PMID:29454110
Abstract

PURPOSE

To evaluate the utility of fat fraction (FF) for the differentiation of different breast tissues and in various breast tumor subtypes using in vivo proton (H) magnetic resonance spectroscopy (MRS).

METHODS

H MRS was performed on 68 malignant, 35 benign, and 30 healthy volunteers at 1.5 T. Malignant breast tissues of patients were characterized into different subtypes based on the differences in the expression of hormone receptors and the FF was calculated. Further, the sensitivity and specificity of FF to differentiate malignant from benign and from normal breast tissues of healthy volunteers was determined using receiver operator curve (ROC) analysis.

RESULTS

A significantly lower FF of malignant (median 0.12; range 0.01-0.70) compared to benign lesions (median 0.28; range 0.02-0.71) and normal breast tissue of healthy volunteers (median 0.39; range 0.06-0.76) was observed. No significant difference in FF was seen between benign lesions and normal breast tissues of healthy volunteers. Sensitivity and specificity of 75% and 68.6%, respectively was obtained to differentiate malignant from benign lesions. For the differentiation of malignant from healthy breast tissues, 76% sensitivity and 74.5% specificity was achieved. Higher FF was seen in patients with ER-/PR- status as compared to ER+/PR+ patients. Similarly, FF of HER2neu+ tumors were significantly higher than in HER2neu- breast tumors.

CONCLUSION

The results showed the potential of in vivo H MRS in providing insight into the changes in the fat content of different types of breast tissues and in various breast tumor subtypes.

摘要

目的

利用体内质子(H)磁共振波谱(MRS)评估脂肪分数(FF)在鉴别不同乳腺组织及各种乳腺肿瘤亚型中的效用。

方法

对68例恶性、35例良性和30例健康志愿者在1.5T条件下进行H MRS检查。根据激素受体表达差异将患者的恶性乳腺组织分为不同亚型,并计算FF。此外,使用受试者工作特征曲线(ROC)分析确定FF区分恶性与良性以及健康志愿者正常乳腺组织的敏感性和特异性。

结果

观察到恶性病变(中位数0.12;范围0.01 - 0.70)的FF显著低于良性病变(中位数0.28;范围0.02 - 0.71)和健康志愿者的正常乳腺组织(中位数0.39;范围0.06 - 0.76)。良性病变与健康志愿者的正常乳腺组织之间的FF无显著差异。区分恶性与良性病变的敏感性和特异性分别为75%和68.6%。区分恶性与健康乳腺组织时,敏感性为76%,特异性为74.5%。与ER+/PR+患者相比,ER-/PR-状态患者的FF更高。同样,HER2neu+肿瘤的FF显著高于HER2neu-乳腺肿瘤。

结论

结果表明体内H MRS在洞察不同类型乳腺组织及各种乳腺肿瘤亚型脂肪含量变化方面具有潜力。

相似文献

1
Study of lipid metabolism by estimating the fat fraction in different breast tissues and in various breast tumor sub-types by in vivo H MR spectroscopy.通过体内氢磁共振波谱法估计不同乳腺组织和各种乳腺肿瘤亚型中的脂肪分数来研究脂质代谢。
Magn Reson Imaging. 2018 Jun;49:116-122. doi: 10.1016/j.mri.2018.02.004. Epub 2018 Feb 14.
2
Efficacy of single voxel 1H MR spectroscopic imaging at 3T for the differentiation of benign and malign breast lesions.3T 单体素 1H 磁共振波谱成像在鉴别乳腺良恶性病变中的效能
Clin Imaging. 2016 Sep-Oct;40(5):831-6. doi: 10.1016/j.clinimag.2016.03.007. Epub 2016 Mar 12.
3
Quantitative in vivo proton MR spectroscopic assessment of lipid metabolism: Value for breast cancer diagnosis and prognosis.定量活体质子磁共振波谱评估脂质代谢:用于乳腺癌诊断和预后的价值。
J Magn Reson Imaging. 2019 Jul;50(1):239-249. doi: 10.1002/jmri.26622. Epub 2019 Jan 3.
4
Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.3T氢磁共振波谱在乳腺肿瘤诊断中的应用价值
Acta Radiol. 2013 May;54(4):380-8. doi: 10.1177/0284185113475921. Epub 2013 Apr 30.
5
In vivo proton magnetic resonance spectroscopy of breast lesions: an update.乳腺病变的体内质子磁共振波谱分析:最新进展
Breast Cancer Res Treat. 2007 Sep;104(3):249-55. doi: 10.1007/s10549-006-9412-8. Epub 2006 Oct 19.
6
Diagnostic value of breast proton magnetic resonance spectroscopy at 1.5T in different histopathological types.1.5T乳腺质子磁共振波谱在不同组织病理学类型中的诊断价值
ScientificWorldJournal. 2012;2012:508295. doi: 10.1100/2012/508295. Epub 2012 May 1.
7
In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.使用3.0-T磁共振成像扫描仪对大的局灶性肝病变进行体内质子磁共振波谱分析以及肝细胞癌经动脉化疗栓塞前后的代谢物变化
J Magn Reson Imaging. 2004 May;19(5):598-604. doi: 10.1002/jmri.20046.
8
Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.在 3T MRI 上使用单体素质子 MRS 对乳腺良恶性病变进行鉴别,可提高诊断准确性。
Clin Radiol. 2013 Sep;68(9):e502-10. doi: 10.1016/j.crad.2013.04.002. Epub 2013 May 23.
9
Comparison of chemical shift-encoded water-fat MRI and MR spectroscopy in quantification of marrow fat in postmenopausal females.化学位移编码水脂磁共振成像与磁共振波谱在绝经后女性骨髓脂肪定量中的比较
J Magn Reson Imaging. 2017 Jan;45(1):66-73. doi: 10.1002/jmri.25351. Epub 2016 Jun 24.
10
Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy.利用体内氢磁共振波谱对人肿瘤性和正常乳腺组织进行特征分析。
J Magn Reson Imaging. 1999 Aug;10(2):159-64. doi: 10.1002/(sici)1522-2586(199908)10:2<159::aid-jmri8>3.0.co;2-0.

引用本文的文献

1
Magnetic Resonance Spectroscopy for Cervical Cancer: Review and Potential Prognostic Applications.宫颈癌的磁共振波谱分析:综述及潜在的预后应用
Cancers (Basel). 2024 Jun 5;16(11):2141. doi: 10.3390/cancers16112141.
2
MR spectroscopy in breast cancer metabolomics.乳腺癌代谢组学中的磁共振波谱分析
Anal Sci Adv. 2021 May 3;2(11-12):564-578. doi: 10.1002/ansa.202000160. eCollection 2021 Dec.
3
Probing lipids relaxation times in breast cancer using magnetic resonance spectroscopic fingerprinting.利用磁共振波谱指纹技术探测乳腺癌中脂质弛豫时间。
Eur Radiol. 2023 May;33(5):3744-3753. doi: 10.1007/s00330-023-09560-w. Epub 2023 Mar 28.
4
Correlated MR spectroscopic imaging of breast cancer to investigate metabolites and lipids: acceleration and compressed sensing reconstruction.乳腺癌的相关磁共振波谱成像以研究代谢物和脂质:加速与压缩感知重建
BJR Open. 2022 Oct 12;4(1):20220009. doi: 10.1259/bjro.20220009. eCollection 2022.
5
Overview of Artificial Intelligence in Breast Cancer Medical Imaging.乳腺癌医学成像中的人工智能概述
J Clin Med. 2023 Jan 4;12(2):419. doi: 10.3390/jcm12020419.
6
Magnetic Resonance Imaging (MRI) and MR Spectroscopic Methods in Understanding Breast Cancer Biology and Metabolism.磁共振成像(MRI)及磁共振波谱方法在理解乳腺癌生物学与代谢方面的应用
Metabolites. 2022 Mar 27;12(4):295. doi: 10.3390/metabo12040295.
7
Fat Composition Measured by Proton Spectroscopy: A Breast Cancer Tumor Marker?通过质子光谱法测量的脂肪成分:一种乳腺癌肿瘤标志物?
Diagnostics (Basel). 2021 Mar 21;11(3):564. doi: 10.3390/diagnostics11030564.
8
Intra-tumoural lipid composition and lymphovascular invasion in breast cancer via non-invasive magnetic resonance spectroscopy.通过非侵入性磁共振波谱分析乳腺癌瘤内脂质成分与淋巴管浸润情况
Eur Radiol. 2021 Jun;31(6):3703-3711. doi: 10.1007/s00330-020-07502-4. Epub 2020 Dec 3.
9
Phased-array combination of 2D MRS for lipid composition quantification in patients with breast cancer.二维磁共振波谱相位阵列组合在乳腺癌患者脂质成分定量中的应用。
Sci Rep. 2020 Nov 18;10(1):20041. doi: 10.1038/s41598-020-74397-y.
10
In vivo MR spectroscopy for breast cancer diagnosis.用于乳腺癌诊断的活体磁共振波谱分析
BJR Open. 2019 Jul 2;1(1):20180040. doi: 10.1259/bjro.20180040. eCollection 2019.